A phase II study of [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-overexpressing or -mutated advanced non-small cell lung cancer Meeting Abstract
| Authors: | Planchard, D.; Li, B. T.; Murakami, H.; Shiga, R.; Lee, C. C.; Wang, K.; Jänne, P. A. |
| Abstract Title: | A phase II study of [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-overexpressing or -mutated advanced non-small cell lung cancer |
| Meeting Title: | 2018 European Lung Cancer Congress (ELCC) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Apr 10-13 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-04-01 |
| Start Page: | mdz063.081 |
| Language: | English |
| ACCESSION: | WOS:000478089000181 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz063.081 |
| Notes: | Meeting Abstract: 183TiP -- Appears on pages ii66-ii67 of the abstract book -- Source: Wos |
